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Abstract
Background: Isotonic blood volume expansion (BVE) induced alterations of sympathetic and parasympathetic activity in 
the heart and blood vessels, which can be modulated by serotonergic pathways. 
Objective: To evaluate the effect of saline or serotonergic agonist (DOI) administration in the hypothalamic paraventricular 
nucleus (PVN) on cardiovascular responses after BVE.
Methods: We recorded pulsatile blood pressure through the femoral artery to obtain the mean arterial pressure (MAP), 
systolic (SBP) and diastolic blood pressure (DBP), heart rate (HR) and the sympathetic-vagal ratio (LF/HF) of Wistar rats 
before and after they received bilateral microinjections of saline or DOI into the PVN, followed by BVE.
Results: No significant differences were observed in the values of the studied variables in the different treatments from the 
control group. However, when animals are treated with DOI followed by BVE there is a significant increase in relation to the 
BE control group in all the studied variables: MBP (114.42±7.85 vs 101.34±9.17); SBP (147.23±14.31 vs 129.39±10.70); 
DBP (98.01 ±4.91 vs 87.31±8.61); HR (421.02±43.32 vs 356.35±41.99); and LF/HF ratio (2.32±0.80 vs 0.27±0.32).
Discussion: The present study showed that the induction of isotonic BVE did not promote alterations in MAP, HR and LF/
HF ratio. On the other hand, the injection of DOI into PVN of the hypothalamus followed by isotonic BVE resulted in a 
significant increase of all variables.  
Conclusion: These results suggest that serotonin induced a neuromodulation in the PVN level, which promotes an inhibition 
of the baroreflex response to BVE. Therefore, the present study suggests the involvement of the serotonergic system in the 
modulation of vagal reflex response at PVN in the normotensive rats. (Arq Bras Cardiol. 2017; 108(2):154-160)
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BVE also promotes an increase in the plasma concentrations 
of oxytocin (Oxt), mainly synthesized in the paraventricular 
nucleus (PVN) and in the supraoptic nucleus of the 
hypothalamus (SON).4 Evidence that Oxt acts as an important 
neuromodulator of the autonomic control of the circulation 
stemmed from studies in which projections of the PVN to 
the NST were observed and reinforced by the observation 
that manipulations in PVN’s oxytocinergic system resulted 
in deep alterations in cardiovascular responses to stress and 
peptidergic stimuli.5-8
The participation of serotonergic mechanisms (5-HT) 
in PVN responses has also been studied, especially 5-HT 
action on 5-HT1A and 5-HT2A receptors. Authors have 
demonstrated the presence of 5-HT1A and 5-HT2A receptors 
and their respective mRNA in PVN. Moreover, researchers 
have verified the co-expression of 5-HT1A and 5-HT2A 
receptors in PVN regions, and a sub-population of these 
neurons presented double marking, 5-HT2A/Oxt, showing 
evidence of 5-HT participation in the activation of these 
receptors in PVN.9,10 Raphe dorsal nucleus afference to PVN 
regions and the significant density of 5-HT receptors in these 
hypothalamic nuclei have been described by several authors, 
and these results show that neuroendocrine responses to 
volume alterations may be modulated by 5-HT activating 
5-HT1A and/or 5-HT2A receptors in the PVN.
11,12
Introduction
Isotonic blood volume expansion (BVE) induces the activation 
of several areas of the brain that are important in cardiovascular 
and neuroendocrine adjustments.1,2 BVE activates baroreflex, 
which promotes hypotension and bradycardia through the 
excitation of two neural pathways. Hypotension involves 
excitatory projections of the nucleus of the solitary tract (NST) 
to the caudal ventrolateral area of the medulla oblongata, and 
when activated, promotes inhibition of the rostral ventrolateral 
area of the medulla oblongata, sympathetic-inhibitory pathway, 
which results in the decrease of sympathetic tone to the heart, 
reduction of total peripheral resistance, and increase of venous 
capacitance. Bradycardia involves an excitatory projection of 
the NST to parasympathetic preganglionic neurons in the dorsal 
motor nucleus of the vagus and nucleus ambiguous, leading to 
an increase of vagal efferent in the heart.3,4
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Based on the neuro-anatomical evidence of PVN oxytocinergic 
projections to NST and in works that have demonstrated serotonin 
neuromodulation over Oxt secretion, which is increased during 
isotonic BVE, we aim to evaluate serotonergic neuromodulation 
over 5-HT2 receptors in cardiovascular responses of the PVN in 
basal conditions or induced by BVE.
Methods
Animals
Thirteen male Wistar rats, weighing between 250-300 
g in the beginning of the experiments were obtained and 
kept in the vivarium Biotério da Disciplina de Fisiologia at 
the University Universidade Federal do Triângulo Mineiro 
(UFTM), acclimatized to the controlled room temperature 
of 23 ± 2°C, with a light-dark cycle of 12h (light – 7 a.m. 
to 7 p.m.), with food and water ad libitum. These animals 
were divided into two groups: Control (N=8), and DOI 
(N=5). All experiments were done between 8 a.m. and 1 
p.m., and were previously approved by the Ethics Committee 
on Animal Experimentation (CEUAUFTM) under protocol 
number 273.
Habituation of the animals to experimental procedures
To decrease the influence of stress promoting factors at 
the time of experiments, the rats were handled daily and 
trained, for seven days, with the maneuvers used in the 
experimental protocol, such as: cleaning of the cannula and 
soft massage in the supra-pubic region for at least one week 
before the experiment.
Experimental protocol
Cannulas in the PVN
The rats were anaesthetized with tribromoethanol (150mg/
kg) and fixed to a stereotaxic device (Insight Equipamentos – 
model ETX3/99, São Paulo, Brazil). Two anthropometric points 
of the skull – bregma (union point of sagittal and coronal 
sutures) and lambda (union point of sagittal and lambdoid 
sutures) – were used as a reference to level the animals’ heads 
in the horizontal plane. The the bregma, we determined the 
points for the bilateral introduction of the cannula in the rats’s 
PVN. In these points, we made trepanations of the skull bones 
with a spherical drill, by opening two orifices of approximately 
1.5 mm in diameter. In the PVN, stainless steel cannulas (12 x 
0.55 mm d.i) were bilaterally positioned in the brain per the 
coordinates: 1.2 mm caudal to bregma; 0.5 mm lateral to the 
median line; and 5.0 mm under the dura-meter, according to 
the coordinates from the Atlas by Paxinos and Watson.13 The 
cannulas were positioned 2 mm above the PVN, and fixed to 
the skull with screws and acrylic dental resin. Metal chucks (0.3 
mm d.i) were used to obliterate the cannulas. The rats received 
prophylactic injections of penicillin (20,000 units, i.m.). During 
the six days of recovery, before cannulation of the veins and 
femoral arteries, the rats were handled and trained daily for 
the procedure and cleaning of the chucks to reduce possible 
influences of stress responses due to animal manipulation. 
Cannulation of femoral veins and arteries
For the cardiovascular record of the conscious animals, on the 
day before the experiment, the animals were anaesthetized with 
tribromoethanol (150 mg/kg) for the implantation of polyethylene 
catheters (PE-50 and PE-10) in the abdominal aorta through the 
femoral artery to record the BP, and in the femoral vein to perform 
the BVE. After implantation, the cannulas were properly filled 
with a physiological solution and subcutaneously exteriorized in 
the posterior region of the neck. Before starting to record, the 
cannulas were heparinized (heparin 2% in physiological solution) 
to avoid the formation of clots. 
Cardiovascular records
After 24 hours of surgical recovery, the cannulas were 
washed with heparinized saline solution (0.1 mL of heparin 
sodium 25000 UI, Liquemine®, Roche, Rio de Janeiro, Brazil, 
dissolved in 20 mL of saline 0.9%). The arterial catheter was 
connected to a PA transducer (P23Db, Gould-Statham), and 
the signs of pulsatile BP were recorded in basal conditions for 
30 minutes, and the signal was converted by an analogue-
digital board (CODAS, with a sample frequency – 4 kHz, 
Di220 Dataq Instruments, Inc., Akron, OH, USA). During the 
experimental procedure, MBP and HR were derived from the 
pulsatile BP. During the recording, the animals stayed in a room 
with noise control, at a temperature of 27°C. After positioning 
of the animals and connection to the equipment, there was a 
15-minute adaptation period before recording began. After 
adaptation of the animals and adequation of signal caption, we 
began the continuous recording of pulsatile BP for 30 minutes 
to obtain basal values of BP and HR. 
Microinjections of saline or drug in the brain
Thirty minutes after recording began, saline (1.0 µg/200 ηL; 
n=8 animals) or serotoninergic dimethoxy-4-iodoamphetamine 
hydrochloride (DOI – 1.0 µg/200 ηL; n=5 animals) dissolved 
in physiological saline solution were bilaterally injected in the 
PVN of the rats using a Hamilton syringe (5 µL) connected by a 
PE-10 polyethylene tube to an injection needle introduced into 
the brain by the guide cannula, previously fixed to the brain. 
During and after the intracerebroventricular microinjections, 
animal records were done in a period of 30 minutes. 
Blood volume expansion (BVE)
Sixty minutes after beginning the recording, some animals 
underwent BVE, performed through intravenous infusion 
(femoral vein) of isotonic NaCL (0.15 M) in a volume of 2 
ml/100 g of body weight during 60 seconds. During and after 
BVE, animal records were done in a 15-minute period. 
Recording of pulsatile BP
On the day of the experiment, between 8 and 9 a.m., 
the animals were weighed and the arterial cannula was 
connected to a pressure transducer; basal pulsatile BP was 
recorded for 30 minutes. After this period, the animals 
received microinjections of DOI in the PVN (1.0 µg/200 ηL; 
n=5 animals) or the same volume of vehicle (isotonic saline; 
n=8 animals). After 30 minutes, the animals underwent 
isotonic BVE (NaCl 0.15 M/ 2 ml100 g weight), and the 
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pressure was continuously recorded for another 15 minutes 
(Figure 1) (supplementary figure). After 75 minutes of recording, 
the animals were euthanized with thiopental sodium (100 mg/
Kg) and their brains were removed and fixed in 10% formalin 
for a few days. Cross sections (40 µm thick) were done in the 
points of PVN injection with a freezing microtome (MICROM, 
model HM 5000 M). Histologic sections, assembled onto 
slides, were stained by the Nissl method and analysed for PVN 
injection points according to the Atlas by Paxinos and Watson.13
Study of the variability of BP and HR
Pulsatile BP was processed by a specific software that 
determined, beat-by-beat, SBP and HR values. HR, SBP, and 
DBP variability was also evaluated in the frequency domain, 
with the autoregressive spectral analysis method.14,15
Pulse Intervals (IP), SBP, and DBP time series, collected 
during 30 basal minutes, were divided into serial segments 
of 300 beats, and all successive segments overlapped in 50% 
with the previous segment (Welch method). Using stationary 
segments of the time series, autoregressive parameters were 
estimated through the Levinson-Durbin method, and the 
model order was chosen according to Akaike’s criterion.15 
After that, over each individual stationary segment of 300 
beats, spectral decomposition was done. Normalization of 
values minimizes interference of the total potency over the 
components; normalization procedure was done by diving 
the potency of the low frequency component (LF – 0,15-0,4 
Hz) or the high frequency component (HF – 0,04-0,15 Hz) 
by the total spectral potency, from which we subtracted 
the potency of the very low frequency band (VLF – 0,01-
0,20 Hz), and then multiplied the result by 100.15 Spectral 
parameters obtained for each individual stationary segment 
of 300 beats were measured, and mean result values for the 
30 basal minutes were collected for each animal. Quotient 
between LF and HF (LF/HF ratio) was used to express the 
sympathetic-vagal balance.16
Statistical analysis
Statistical analysis was done through the software R, 
version 3.3.0. The obtained results were presented as 
mean ± standard deviation of the mean. To confirm that 
all continuous variables were normally distributed, we used 
the Kolmogorov-Smirnov test, and afterwards, to evaluate 
the effects of groups and evaluations in relation to SBP, 
DBP, MBP, HR, and LF/HF variables we used the two-way 
ANOVA with measurements, and Bonferroni’s method of 
multiple comparisons. Significance level was set at 5%. 
Results
Table 1 shows the results (mean ± standard deviation 
of the mean) of the cardiovascular variables of the control 
group animals (C) and of the DOI group animals (D). No 
significant differences were observed in the control group 
between the values obtained in basal period (Cb), after 
microinjection with saline (Cm), and saline followed by 
isotonic BVE (Ce) in the variables MBP, SBP, and DBP. 
DOI microinjection (Dm) and DOI followed by BVE (De) 
significantly increased MBP (Figure 2), SBP, and DBP 
in relation to the control group (Ce) (114.42±7.85 vs 
101.34±9.17; 147.23±14.31 vs 129.39±10.70; and 
98.01±4.91 vs 87.31±8.61, respectively).
Animals in the control group presented significant 
difference in basal HR values (Cb), with microinjection 
of saline (Cm) and saline followed by BVE, in relation 
the DOI group with the same treatments (Db, Dm, and 
De) (354.14±29.53 vs 399.40±25.09; 356.14±32.09 
vs 405.08±41.09 and 356.35±41.99 vs 421.02±43.32, 
respectively). DOI microinjection (Dm), and DOI followed 
by BVE (De), increased the LF/HF ratio in relation to control 
animals who received saline microinjection (Cm) and saline 
followed by isotonic BVE (Ce) (2.45±0.82 vs 0.55±0.22 
and 2.32±0.80 vs 0.27±0.32, respectively).
All p values obtained from statistical analysis of the studied 
variables are depicted in Table 2 (supplementary data).
Discussion
Our study showed that isotonic BVE did not promote 
alterations in MBP, SBP, and DBP, or in HR and sympathetic-
vagal ratio (LF/HF). As previously shown by other authors, 
Figure 1 – Representative scheme of the seven days of experimental protocol of the groups Control and Serotoninergic Agonist (DOI). PVN: paraventricular nuclei of 
the hypothalamus; BP, pulsatile BP; HR, BVE HR, extracellular volume expansion with isotonic saline (supplementary figure).
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acute BVE induces a series of hemodynamic events, 
including an increase in central venous pressure, right atrial 
pressure, central and peripheral blood volume, cardiac 
debit, and systolic volume. On the other hand, HR decreases 
significantly, and total peripheral resistance decreases slightly 
during volume overload, while MBP remains unaltered.17 
These findings differ from those obtained by Godino et al., 
2005, who performed BVE through infusion of a great intra 
atrial volume for one minute and observed a reduction 
not only in HR, but also in MBP. This hypotension can be 
mediated by a quick and pronounced release of oxytocin 
and atrial natriuretic peptide, which have a diuretic 
and vasodilatory effect.18 Moreover, these peptides are 
involved in the baroreflex control of the HR, facilitating 
vagal response in the increase of reflex bradycardia during 
baroreceptor discharge.19-23
In the present work, the animals who received 
intracerebroventricular microinjection of the serotonergic 
agonist DOI in the PVN, followed by BVE, presented a 
significant increase in MBP, SBP, DBP, HR, and LF/HF, 
suggesting that the serotonergic agonist DOI leads to the 
inhibition of Oxt secretion as a response to BVE, when it is 
bilaterally microinjected into the PVN, or even that is exerts 
a neuromodulation in the PVN level, which then promotes 
an inhibition in the baroreflex response to BVE.
Table 1 – Mean values (± standard deviation of the mean) of mean blood pressure (MBP), systolic blood pressure (SBP), and diastolic blood 
pressure (DBP), heart rate  (HR), low frequency component (LF), and high frequency component (HF) of the animals of the basal control 
groups (Cb), post saline microinjection in the paraventricular nuclei of the hypothalamus (Cm), control after expansion of the extracellular 
volume (Ce), and those treated with DOI, in the basal state (Db), after DOI microinjection in the paraventricular nuclei of the hypothalamus 
(Dm), and after expansion of the extracellular volume (De)
 Variables Cb Cm Ce Db Dm De
MBP (mmHg) 100.83 ± 7.98 99.79 ± 7.24 101.34 ± 9.17 105.65 ± 2.25 108.79 ± 9.31 114.42 ± 7.85#  ɤ
SBP (mmHg) 130.28 ± 7.62 129.66 ± 6.49 129.39 ± 10.70 136.05 ± 2.74 141.11 ± 14.95 147.23 ± 14.31&*
DBP (mmHg) 86.10 ± 8.53 84.86 ± 7.97 87.31 ± 8.61 90.46 ± 3.63 92.63 ± 6.50 98.01 ± 4.91+ %
HR (bpm)) 354.14 ± 29.53 356.14 ± 32.09 356.35 ± 41.99 399.40 ± 25.09$ 405.08 ± 41.09α 421.02 ± 43.32β
LF/HF ratio 0.36 ± 0.20 0.55 ± 0.22 0.27 ± 0.32 0.67 ± 0.68 2.45 ± 0.82** 2.32 ± 0.80##
#p=0.018 vs MBP Ce; ɤp=0.016 vs MBP Db; &p=0.010 vs SBP Ce; *p=0.035 vs SBP Db;+p=0.047 vs DBP Ce; %p=0.022 vs DBP Db;$p=0.034 vs HR Cb;
 αp=0.033 vs HR Cm; βp=0.010 vs HR Ce; **p=0.001 vs LF/HF ratio Cm and Db; ##p=0.001 vs LF/HF Ce eDb.
Figure 2 – Mean values (± standard deviation of the mean) of the MBP of the basal control group animals (Cb), control after microinjection of saline (Cm), control after 
extracellular volume expansion (Ce) and those treated with DOI, in the basal state (Db), after DOI microinjection (Dm), and after extracellular volume expansion (De). 
#p=0.018 vs MBP Ce; ɤp=0.016 vs MBP Db.
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Intravenous administration of 8-OHDPAT (5-HT1A 
receptor agonist) or DOI (5-HT2A receptor agonist) promotes 
an increase in plasma concentrations of Oxt. Both responses 
are significantly attenuated when the animals receive 
intravenous pre-treatment with antagonists of these receptor, 
suggesting that this increase occurs by the serotoninergic 
activation of these receptors, instead of stimulation by 
interneurons.11,12,24,25 5-HT2A receptors stimulation in the 
central nervous system can induce an increase in BP, partly 
through the increase in vasoconstrictor sympathetic activity 
due to sympathetic premotor neuron activation in the 
rostral ventrolateral medulla oblongata, and also through 
vasopressin release.26
 PVN is reciprocally connected to several other 
areas of the brain involved in the cardiovascular function 
control.27 PVN also contains pre-autonomic neurons, which 
directly and indirectly project to sympathetic preganglionic 
neurons inside the spinal cord mediolateral cell column, via 
the rostral ventrolateral medulla oblongata.28
Several studies have reported the contribution of PVN 
parvocellular neurons in the compensatory autonomic 
response during physical training for volume overload, 
suggesting that the volume overload stimulates vagal cardiac 
receptors, especially by the activation of PVN parvocellular 
neurons, which successively induces the inhibition of 
the sympathetic nervous activity.29-35 Several works have 
suggested that the increase in neuron activity in the PVN 
is associated to sympathetic excitation during cardiac 
collapse.36-38 Moreover, some works have found that an 
altered GABAergic mechanism in the PVN may be involved 
in the regulation of the sympathetic afferent in the cardiac 
collapse, and that alterations in the inhibitory mechanism 
can contribute to an increase in sympathetic activity.39-40
This is the first study to explore serotoninergic neuromodulation 
via 5-HT2A receptors in the PVN level about cardiovascular 
responses to isotonic BVE, which proved to be inhibitory. 
However, it is noteworthy that further, more in depth studies 
are necessary to check if this neuromodulation directly affects 
sympathetic and/or baroreflex activity or if it is accompanied by 
neuroendocrine alterations, especially concerning Oxt, arginine, 
vasopressin, and atrial natriuretic peptide secretion. 
Conclusion
The present work provides evidence that serotonin 
performs neuromodulation in the PVN level, which promotes 
an inhibition of the baroreflex response to BVE. Thus, 
this work suggests the serotoninergic involvement in the 
neuromodulation in the PVN level in the vagal reflex response 
in normotensive rats. 
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Table 2 – p values obtained after comparisons between the groups Control (n=8) and DOI (dimethoxy-4-iodoamphetamine) (n=5) of the studies 
variables: mean blood pressure (MBP), systolic blood pressure (SBP), and diastolic blood pressure (DBP), heart rate  (HR), low frequency component 
(LF), and high frequency component (HF) of the animals of the basal control groups (Cb), post saline microinjection in the paraventricular nuclei 
of the hypothalamus (Cm), control after expansion of the extracellular volume (Ce), and those treated with DOI, in the basal state (Db), after DOI 
microinjection in the paraventricular nuclei of the hypothalamus (Dm), and after expansion of the extracellular volume (De). Variance analysis with 
repeated measurements and Bonferroni’s multiple comparison method were employed in this study. Significance level was set at p<0.05
Comparisons MBP SBP DBP HR LF/HF
Cb vs Cm 0.827 0.937 0.568 0.987 0.704
Cb vsCe 0.828 0.930 0.568 0.988 0.755
Cm vs Ce 0.820 0.934 0.560 0.980 0.704
Db vs Dm 0.293 0.234 0.418 0.730 0.001
Db vs De 0.016 0.035 0.022 0.503 0.001
Dm vs De 0.096 0.230 0.075 0.500 0.711
Cb vs Db 0.287 0.316 0.308 0.034 0.290
Cm vs Dm 0.077 0.076 0.110 0.033 0.001
Ce vs De 0.018 0.010 0.047 0.010 0.001
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